News and publications
Promethera Biosciences to be present at J.P. Morgan Healthcare Conference 2016
Promethera Biosciences will be participating to the 34th edition of the annual J.P. Morgan Healthcare Conference which will be held from 11 to 15 January 2016 in San Francisco.
The J.P. Morgan Healthcare conference is the biggest healthcare investment event and attracts a broad range of analysts and institutional investors.
John Tchelingerian - CEO, and Frank Hazevoets - CFO and Head Corporate Development - will be present to meet with investors and potential partners and share with them Promethera's strategic vision for future developments.
PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01